Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Nicolae Testemițanu State University of Medicine and Pharmacy

Nom variantlari: Universitatea de Medicină și Farmacie Nicolae Testemițanu din Chișinău · Universitatea de Stat de Medicină și Farmacie "Nicolae Testemițanu" · Государственный университет медицины и фармакологии имени Николая Тестемицяну

Davlat:
MD
ROR:
https://ror.org/03xww6m08
2
h-indeks
4
Iqtiboslar
13
Asarlar
15
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
01345012018201920202021202220232024202520262018: Nashrlar 2, Iqtiboslar 02019: Nashrlar 1, Iqtiboslar 02020: Nashrlar 0, Iqtiboslar 12021: Nashrlar 3, Iqtiboslar 12022: Nashrlar 2, Iqtiboslar 02023: Nashrlar 2, Iqtiboslar 12024: Nashrlar 1, Iqtiboslar 02025: Nashrlar 1, Iqtiboslar 12026: Nashrlar 1, Iqtiboslar 0

Iqtibos tarixi

012018201920202021202220232024202520262018: Iqtiboslar 02019: Iqtiboslar 02020: Iqtiboslar 12021: Iqtiboslar 12022: Iqtiboslar 02023: Iqtiboslar 12024: Iqtiboslar 02025: Iqtiboslar 12026: Iqtiboslar 0

Nashr tarixi

013452018201920202021202220232024202520262018: Nashrlar 22019: Nashrlar 12020: Nashrlar 02021: Nashrlar 32022: Nashrlar 22023: Nashrlar 22024: Nashrlar 12025: Nashrlar 12026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0122018201920202021202220232024202520262018: h-indeks 02019: h-indeks 02020: h-indeks 12021: h-indeks 12022: h-indeks 12023: h-indeks 12024: h-indeks 12025: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia20232 iqtibos
  2. HIV care in Central and Eastern Europe: How close are we to the target?20180 iqtibos
  3. What is the quality of the maternal near-miss case reviews in WHO European Region? Cross-sectional study in Armenia, Georgia, Latvia, Republic of Moldova and Uzbekistan20180 iqtibos
  4. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)20210 iqtibos
  5. Состояние проблемы остеопороза в странах Евразийского региона20210 iqtibos
  6. Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients20210 iqtibos
  7. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 202120220 iqtibos
  8. The third ethical commentary to COVID-19 (two years later) — vaccination, solidarity, and trust20220 iqtibos
  9. Update on HPV Vaccination Policies and Practices in 17 Eastern European and Central Asian Countries and Territories20230 iqtibos
  10. V International expert forum on menopausal hormone therapy20240 iqtibos